“Tackling Corrupt Practices: GSK China ” by Meyer, K. in Peng, K. and Meyer, K. (2016) pp. 544 – 549

/in /by

Read the case entitled: “Tackling Corrupt Practices: GSK China ” by Meyer, K. in Peng, K. and Meyer, K. (2016) pp. 544 – 549 and answer the following questions:

  1. Using the “four risks of international business”, assess the risks facing GlaxoSmithKline (GSK) in doing business in China (40 marks)

  2. With reference to the GSK China case study, identify and discuss the factors responsible for the corrupt practices in Chinese pharmaceutical/medical industry. In what various ways can the Chinese government discourage corrupt practices in the pharmaceutical/medical industry? (30 marks)

  3. Explain how GlaxoSmithKline (GSK) can use Corporate Social Responsibility (CSR) and Corporate Governance Practices to tackle the corrupt practices in the Chinese Pharmaceutical/Medical Industry. What does GSK stand to gain from the implementation of CSR and Corporate Governance initiatives in its operations in China? (30 marks)

"Order a similar paper and get 15% discount on your first order with us
Use the following coupon
"FIRST15"

Order Now
You might also like
Professional Ethics in Organization Development (or any topic from Chapters 1 – 8 Cummings, T. G. (2015). Organization Development and Change, 10th Edition)
COIT20261 Network Routing and Switching (Term 2, 2018)
Rahat Continental Limited
Training Budget Worksheet
· Identify two items or issues that cannot be derived from the financial statements of the two companies that you selected for your research.
Your Professional Development Portfolio will be a compilation of specific artifacts that should be suitable to present at a job interview or performance review. 
This week, you will complete Part 1 of the Final Project, a plan for integrating a new supplier into the supply chain at Johnson & Johnson (J&J)
Describe users of health information and health information  management functions, based on the key points listed in the Guidelines  section 2